Abstract
F9. A Novel Orally Active Triple Reuptake Inhibitor for the Treatment of Post-Traumatic Stress Disorder (PTSD): D-578 Attenuates Abnormal Fear Behavior in a Rodent Model of Traumatic Stress
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have